‘Ablation devices’ is a minimal invasive medical procedure to destroy the abnormal tissues. It is performed with the help of probes that can be inserted through the skin or by using catheters that can be inserted through an artery or energy beams to reach the area that needs to be treated. An imaging technique such as MRI or rotational angiography is used to guide the probes or catheters to the site during ablation.
The world ablation device market is estimated to grow from $3,047 million in 2015 to $6,658 million by 2022 at a CAGR of 11.7% from 2016 to 2022. This can be attributed to the increase in demand for minimal invasive surgeries and increase in the prevalence of patients with chronic illnesses. Other factors such as minimal damage and blood loss, and short duration are some of the factors that contribute towards the growth of this market. However, stringent government regulations and unstable reimbursement policies restrain the market growth.
Check the DISCOUNT on this report @ http://www.orbisresearch.com/contacts/discount/220781 .
By technology, the ablation devices market is broadly categorized into thermal and non-thermal technologies. Thermal technologies comprise microwave, electrical, light, radiation, ultrasound, radiofrequency, and hydrothermal technologies, and each of these are further subcategorized. Thus, electrical ablation includes electrical ablators and electronic brachytherapy, while light ablation includes cold and exicmer laser. In addition, radiation ablation is sub-categorized into brachytherapy, stereotactic radiotherapy & radiosurgery, stereotactic body radiation, image guided radiation therapy, intensity modulated radiation therapy, and proton beam therapy. While ultrasound ablation is sub-divided into high intensity focused ultrasound (HIFU), magnetic resonance imaging-guided focused ultrasound (MRI-FUS), ultrasonic surgical systems, and shock wave lithotripsy; radiofrequency ablation is sub-divided into temperature controlled, fluid cooled, and catheter manipulation systems. However, the non-thermal technology market comprises cryoablation and hydromechanical ablation, wherein Cryoablation includes tissue contact probe, cryogen spray probe, and epidermal & subcutaneous cryoablation devices.
By applications, the ablation devices market is segmented into cancer, cardiology, ophthalmology, gynecology, urology, orthopedics, and other medical conditions. On the basis of function, the market is divided into automated/robotic and conventional ablation devices. Based on procedure, the market is segmented as aesthetics-skin rejuvenation & tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser- and other energy-based therapies/ holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression & denervation, varicose veins, atrial fibrillation, tumor ablation, and others. By geography, the ablation devices market is categorized into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players. For instance, on 26th January 2016, Medtronic PLC acquired Covidien to expand their access and improve their clinical outcomes at lower cost. Moreover, this acquisition has helped Medtronic PLC to compete with Johnson & Johnson. Boston Scientific Corporation acquired Cosman Medical on July 27, 2016to improve its neuromodulation portfolio and help provide innovative solutions for chronic pain treatment.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/220781 .
Quantitative analysis of the current trends and market estimations from 2014 to 2022 is presented to identify potential market opportunities.
The report provides an in-depth analysis of the market and total revenue generated during the forecast period.
A detailed analysis based on applications and procedures are presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.
For more information contact firstname.lastname@example.org
Some Point’s from Table of Content:
Chapter 1 Introduction
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter 2 Executive Summary
2.1 CXO perspective
Chapter 3 Market Overview
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE mark
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.6.1 Patent analysis, by year
3.6.2 Patent analysis, by company
3.7 Top impacting factors
18.104.22.168 Rise in the prevalence of chronic illnesses
22.214.171.124 Technological advancements
126.96.36.199 Short duration and high efficacy of the procedure
188.8.131.52 Government regulations and reimbursement policies
184.108.40.206 High cost and limited awareness
220.127.116.11 Increase in the level of awareness
18.104.22.168 Untapped markets in emerging economies
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/220781 .
For any enquires before buying, connect with us @ email@example.com
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway, Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch